Search - tctmd.com

Displaying 81 - 92 of 92

Sort: Relevancy | Date

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

Can Amelioration of HDL-C Level by Pitavastatin Improve Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention?

Presentation TCT 2013

Can Amelioration of HDL-C Level by Pitavastatin Improve Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention?

Presenter: Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Amro Elnagar, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong

January 31, 2013

Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

Presentation

Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury

Presenter: C. Quintavalle

November 15, 2012

A Prospective, Randomized Trial of Rosuvastatin Loading Prior to PCI

Presentation TCT 2012

A Prospective, Randomized Trial of Rosuvastatin Loading Prior to PCI

Presenter: Josef Veselka

October 22, 2012

Presentation EuroPCR 2012

ROMA II Reload

Presenter: G. Sardella

May 17, 2012

Accelerated Platelet Inhibition by Switching from Atorvastatin to a Non-CYP3A4-Metabolized Statin

Presentation

Accelerated Platelet Inhibition by Switching from Atorvastatin to a Non-CYP3A4-Metabolized Statin

Presenter: Y. Park

April 24, 2012

Does Aggressive Statin Therapy Reduce Coronary Atherosclerotic Plaque Lipid Content?

Presentation

Does Aggressive Statin Therapy Reduce Coronary Atherosclerotic Plaque Lipid Content?

Presenter: Annapoorna S. Kini

April 04, 2012

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presentation

Impact of Statin Therapy on Late TLR After Sirolimus-Eluting Stent (SES) Implantation

Presenter: 202206|M Natsuaki

March 04, 2012

Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of CLI

Presentation

Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of CLI

Presenter: Francesco A. Aiello

January 26, 2012

El Tratamiento con Estatinas se Asocia a Mejores Resultados Clínicos Tras Tratamiento Endovascular de la ICE

Presentation

El Tratamiento con Estatinas se Asocia a Mejores Resultados Clínicos Tras Tratamiento Endovascular de la ICE

Presenter: Francesco A. Aiello

January 26, 2012

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

Presentation TCT 2012

Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway

Presenter: Paul S. Rees, Derek J. Hausenloy, Derek M. Yellon

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.